Pharma

Your Article Summary

See Latest Articles

CHMP issues positive opinion for Micardis as the first treatment in its class to reduce the risk of cardiovascular morbidity in high CV risk patients
Boehringer Ingelheim, 10/26/09

Boehringer Ingelheim announced that the Committee for Medicinal Products for Human Use of the European Medicines Evaluation Agency has issued a positive opinion for the approval of Micardis for the reduction of cardiovascular morbidity in patients with: I. manifest atherothrombotic cardiovascular disease or II. type 2 diabetes mellitus with documented target organ damage.

Today in Drug/Product Approvals...keeping you current

Receive free subspecialty "5-minute updates" via email

FDA Approves Gardasil to Prevent Genital Warts in Males. Agency Also Approves Bivalent HPV Vaccine for Girls, Young Women
American Family Physician, 10/27/09

Novartis receives FDA approval for Valturna®, a single-pill combination of valsartan and aliskiren, to treat high blood pressure
Novartis, 09/18/09

Salix Receives FDA Marketing Approval for Metozolv
Salix Pharmaceuticals, 09/09/09

See All of Drug/Product Approvals

Today in Medical Devices/Products...keeping you current

Receive free subspecialty "5-minute updates" via email

AstraZeneca submits US New Drug Application for ticagrelor, an investigational antiplatelet agent
AstraZeneca, 11/23/09

FDA Grants Emergency Use Authorization of the Prodesse ProFlu-ST(TM)
Gen-Probe, 10/30/09

Gyrus PlasmaKinetic bipolar coagulation device for liver resection
Australian and New Zealand Journal of Surgery, 11/13/09

See All of Medical Devices/Products